ID: h-cross-synth-grn-lysosomal-microglia
Hypothesis

GRN/progranulin lysosomal insufficiency across FTD, ALS-spectrum stress, and AD inflammation

Shared mechanism across FTD, ALS, AD: Progranulin insufficiency causes tau-negative, ubiquitin-positive FTD and weakens lysosomal handling in neurons and microglia.
🧬 GRN🩺 multi🎯 Composite 76%💱 $0.53▲2.5%active
neurodegeneration
EvidenceStrong (88%)📖 3 cit🗣 1 debates 3 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.74 (15%) Evidence 0.68 (15%) Novelty 0.82 (12%) Feasibility 0.68 (12%) Impact 0.86 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.12 (8%) 0.756 composite

🧪 Overview

Shared mechanism across FTD, ALS, AD: Progranulin insufficiency causes tau-negative, ubiquitin-positive FTD and weakens lysosomal handling in neurons and microglia. That lysosomal/microglial deficit can sensitize TDP-43 proteinopathy in ALS-spectrum disease and intensify AD inflammatory damage even when GRN is not the initiating lesion.

Falsifiable prediction: Restoring progranulin should improve lysosomal acidification and reduce TDP-43 or amyloid-induced microglial cytokine output by at least 20% across GRN-FTD neurons, TDP-43 ALS neurons, and AD microglia co-cultures.

Proposed experiment: Compare recombinant progranulin, GRN gene augmentation, and control treatment in GRN-haploinsufficient cortical neurons, TDP-43 motor-neuron cultures, and AD microglia-neuron co-cultures; assay cathepsin activity, lysosomal pH, TDP-43 aggregation, cytokines, and neuronal survival.

Cross-disease confidence rationale: Direct FTD genetics with mechanistic extension through TDP-43/microglial lysosomal biology.

Internal SciDEX support: SciDEX support query found 17 matching hypotheses across 5 disease labels, including 17 with debate_count > 0.

...

🧬 Mechanism

🔗 Mechanism from KG for GRN

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    GRN["GRN"] -->|cross disease mech| FTD["FTD"]
    GRN_1["GRN"] -->|cross disease mech| ALS["ALS"]
    GRN_2["GRN"] -->|cross disease mech| AD["AD"]
    h_cross_synth_grn_lysosom["h-cross-synth-grn-lysosomal-microglia"] -->|proposes shared me| GRN_3["GRN"]
    style GRN fill:#4fc3f7,stroke:#333,color:#000
    style FTD fill:#ef5350,stroke:#333,color:#000
    style GRN_1 fill:#4fc3f7,stroke:#333,color:#000
    style ALS fill:#ef5350,stroke:#333,color:#000
    style GRN_2 fill:#4fc3f7,stroke:#333,color:#000
    style AD fill:#ef5350,stroke:#333,color:#000
    style h_cross_synth_grn_lysosom fill:#4fc3f7,stroke:#333,color:#000
    style GRN_3 fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix3 supports0 contradicts
Supports
GRN mutations cause tau-negative FTD linked to chromosome 17.
Supports
Null GRN mutations cause ubiquitin-positive FTD.
Supports
TREM2-APOE dysfunctional microglia framework supports inflammatory convergence.
2017PMID:28930663medium

🏥 Translation

🔮 Predicted Protein Structure — GRN

🔮 AlphaFold P28799 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for GRN →

No DepMap CRISPR Chronos data found for GRN.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0004
Events (7d)
1
Price History
▲2.5%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations1 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
Restoring progranulin should improve lysosomal acidification and reduce TDP-43 or amyloid-induced microglial cytokine output by at least 20% across GRN-FTD neurons, TDP-43 ALS neurons, and AD microgliIf this mechanism is real, then Restoring progranulin should improve lysosomal acidification and reduce TDP-43 or amyloid-induced microglial cytokine output by — no observation —pending0.68
🔮 Falsifiable Predictions (1)
pendingconf 68%
Restoring progranulin should improve lysosomal acidification and reduce TDP-43 or amyloid-induced microglial cytokine output by at least 20% across GRN-FTD neurons, TDP-43 ALS neurons, and AD microglia co-cultures.
Predicted outcome: If this mechanism is real, then Restoring progranulin should improve lysosomal acidification and reduce TDP-43 or amyloid-induced microglial cytokine
Falsification: Falsified if the experiment produces results more than 20% below the predicted effect size
Metadatasource: v1_phase_c_backfill · origin_type: cross_disease_synthesis
sourcev1_phase_c_backfill
origin_typecross_disease_synthesis
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.